Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.
Fourteen patients with severe viral illnesses were given intravenous infusions of a modified interferon inducer, polyriboinosinic-polyribocytidylic acid-poly-L-lysine complexed with carboxymethylcellulose [poly)I:C.LC)], during a phase 1 clinical trial. The first eight patients received 0.15 to 0.30...
Na minha lista:
| Publicado no: | Infect Immun |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1979
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC414523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/500189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.25.3.831-837.1979 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|